Clinical trial / 2018
Flaxseed cookies improved constipation symptoms, body weight, glycemic control, and lipid levels in constipated patients with type 2 diabetes.
In a single-blinded randomized controlled trial, 53 constipated patients with type 2 diabetes received either 10 g of flaxseed pre-mixed in cookies twice daily or placebo cookies for 12 weeks. Compared with placebo, the flaxseed group showed statistically significant improvements in absolute change for constipation symptom scores (2.46 vs. 0.41), weight (-3.8 vs. 0.0 kg), BMI (-1.5 vs. -0.1 kg/m2), FPG (-26.7 vs. -1.9 mg/dl), HbA1c (-0.8 vs. 1.0%), cholesterol (-37.3 vs. -10.4 mg/dl), LDLC (-21.0 vs. -4.3 mg/dl), and HDLC (4.7 vs. -4.4 mg/dl; all P < 0.05). Compliance was reported as good, and no adverse effects were observed.
- Study type
- Single-blinded randomized controlled trial
- Who was studied
- 53 constipated patients with type 2 diabetes and BMI 20.5-48.9 kg/m2
- What was measured
- Constipation symptom scores, BMI, weight, FPG, HbA1c, and lipid profile
THE PAPER
A randomized trial of the effects of flaxseed to manage constipation, weight, glycemia, and lipids in constipated patients with type 2 diabetes.
Soltanian N, Janghorbani M. Nutr Metab (Lond), 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.